Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation

Journal of Lipid Research

Volumn 46, Issue 7, 2005, Pages 1369-1379

  Fu, Yuchang ^a   Luo, Nanlan ^a   Klein, Richard L ^b   Timothy Garvey, W ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Adipocytokine; Gene expression; Glucose; Lipid metabolism; Obesity diabetes

Indexed keywords

ADIPONECTIN; BETA GALACTOSIDASE; CCAAT ENHANCER BINDING PROTEIN ALPHA; FAT DROPLET; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRANSCRIPTION FACTOR; CARRIER PROTEIN; CCAAT ENHANCER BINDING PROTEIN; DNA BINDING PROTEIN; FATTY ACID BINDING PROTEIN; GLUCOSE TRANSPORTER; MUSCLE PROTEIN; PPARGC1A PROTEIN, MOUSE; SIGNAL PEPTIDE; SLC2A4 PROTEIN, MOUSE; SREBF1 PROTEIN, MOUSE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSACTIVATOR PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; GLUCOSE TRANSPORT; GLUCOSE TRANSPORT SYSTEM; INSULIN RESPONSE; INSULIN SENSITIVITY; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; STIMULATION; ANIMAL; BIOSYNTHESIS; CELL STRAIN 3T3; CYTOLOGY; DRUG EFFECT; INSULIN RESISTANCE; LIPID METABOLISM; PHYSIOLOGY;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; CARRIER PROTEINS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; FATTY ACID-BINDING PROTEINS; GLUCOSE TRANSPORTER TYPE 4; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID METABOLISM; MICE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; PPAR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 24744457984     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M400373-JLR200     Document Type: Article

References (53)

1. Havel, P. 2002. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr. Opin. Lipidol. 13: 51-59.
2. Arita, Y., S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, J. Miyagawa, K. Hotta, I. Shimomura, T. Nakamura, K. Miyaoka, et al. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257: 79-83.
3. Lindsay, R. S., T. Funahashi, R. L. Hanson, Y. Matsuzawa, S. Tanaka, P. A. Tataranni, W. C. Knowler, and J. Krakoff. 2002. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 360: 57-58.
4. Lindsay, R. S., T. Funahashi, J. Krakoff, Y. Matsuzawa, S. Tanaka, S. Kobes, P. H. Bennett, P. A. Tataranni, W. C. Knowler, and R. L. Hanson. 2003. Genome-wide linkage analysis of serum adiponectin in the Pima Indian population. Diabetes. 52: 2419-2425.
5. Hotta, K., T. Funahashi, N. L. Bodkin, H. K. Ortmeyer, Y. Arita, B. C. Hansen, and Y. Matsuzawa. 2001. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes. 50: 1126-1133.
6. Weyer, C., T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R. E. Pratley, and P. A. Tataranni. 2001. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86: 1930-1935.
7. Waki, H., T. Yamauchi, J. Kamon, Y. Ito, S. Uchida, S. Kita, K. Hara, Y. Hada, F. Vasseur, P. Froguel, et al. 2003. Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J. Biol. Chem. 278: 40352-40363.
8. Fruebis, J., T. S. Tsao, S. Javorschi, D. Ebbets-Reed, M. R. Erickson, F. T. Yen, B. E. Bihain, and H. F. Lodish. 2001. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA. 98: 2005-2010.
9. Yamauchi, T., J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7: 941-946.
10. Berg, A. H., T. P. Combs, X. Du, M. Brownlee, and P. E. Scherer. 2001. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7: 947-953.
11. Combs, T. P., A. H. Berg, S. Obici, P. E. Scherer, and L. Rossetti. 2001. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest. 108: 1875-1881.
12. Yamauchi, T., J. Kamon, Y. Ito, A. Tsuchida, T. Yokomizo, S. Kita, T. Sugiyama, M. Miyagishi, K. Hara, M. Tsunoda, et al. 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 423: 762-768.
13. Yamauchi, T., J. Kamon, Y. Minokoshi, Y. Ito, H. Waki, S. Uchida, S. Yamashita, M. Noda, S. Kita, K. Ueki, et al. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8: 1288-1295.
14. Ouchi, N., S. Kihara, Y. Arita, Y. Okamoto, K. Maeda, H. Kuriyama, K. Hotta, M. Nishida, M. Takahashi, M. Muraguchi, et al. 2000. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-B signaling through a cAMP-dependent pathway. Circulation. 102: 1296-1301.
15. Ouchi, N., S. Kihara, Y. Arita, M. Nishida, A. Matsuyama, Y. Okamoto, M. Ishigami, H. Kuriyama, K. Kishida, H. Nishizawa, et al. 2001. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation. 103: 1057-1063.
16. Yamauchi, T., J. Kamon, H. Waki, Y. Imai, N. Shimozawa, K. Hioki, S. Uchida, Y. Ito, K. Takakuwa, J. Matsui, et al. 2003. Globular adiponectin protected ob/ob mice from diabetes and apoE-deficient mice from atherosclerosis. J. Biol. Chem. 278: 2461-2468.
17. Combs, T. P., U. B. Pajvani, A. H. Berg, Y. Lin, L. A. Jelicks, M. Laplante, A. R. Nawrocki, M. W. Rajala, A. F. Parlow, L. Cheeseboro, et al. 2004. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology. 145: 367-383.
18. Kubota, N., Y. Terauchi, T. Yamauchi, T. Kubota, M. Moroi, J. Matsui, K. Eto, T. Yamashita, J. Kamon, H. Satoh, et al. 2002. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277: 25863-25866.
19. Maeda, N., I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, H. Nagaretani, N. Furuyama, H. Kondo, M. Takahashi, Y. Arita, et al. 2002. Diet-induced insulin resistance in mice lacking adiponectin/ ACRP30. Nat. Med. 8: 731-737.
20. Ma, K., A. Cabrero, P. K. Saha, H. Kojima, L. Li, B. H-J. Chang, A. Paul, and L. Chan. 2002. Increased β-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J. Biol. Chem. 277: 34658-34661.
21. Heilbronm, L. K., S. R. Smith, and E. Ravussin. 2003. The insulin-sensitizing role of the fat derived hormone adiponectin. Curr. Pharm. Des. 9: 1411-1418.
22. Green, H., and O. Kehinde. 1974. Sublines of mouse 3T3 cells that accumulate lipid. Cell. 1: 113-116.
23. Green, H., and O. Kehinde. 1975. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell. 5: 19-27.
24. Green, H., and O. Kehinde. 1976. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells. Cell. 7: 105-113.
25. Rosen, E. D., C. J. Walkey, P. Puigserver, and B. M. Spiegelman. 2000. Transcriptional regulation of adipogenesis. Genes Dev. 14: 1293-1307.
26. Frost, S., and M. Lane. 1985. Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J. Biol. Chem. 260: 2646-2652.
27. Ramirez-Zacarias, J. L., F. Castro-Munozledo, and W. Kuri-Harcuch. 1992. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil Red O. Histochemistry. 97: 493-497.
28. Mayor, P., L. Maianu, and W. T. Garvey. 1992. Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes: effects on glucose transporter gene expression. Diabetes. 41: 274-285.
29. Fingar, D. C., S. Hausdorff, J. Blenis, and M. J. Birnbaum. 1993. Dissociation of pp70 ribosomal protein S6 kinase from insulin-stimulated glucose transport in 3T3-L1 adipocytes. J. Biol. Chem. 268: 3005-3008.
30. Robinson, L., S. Pang, D. Harris, J. Heuser, and D. E. James. 1992. Translocation of the glucose transporter (GLUT4) to the cell surface in permeabilized 3T3-L1 adipocytes: effects of ATP insulin, and GTP gamma S and localization of GLUT4 to clathrin lattices. J. Cell Biol. 117: 1181-1196.
31. Nelson, B. A., K. A. Robinson, and M. G. Buse. 2000. High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes. 49: 981-991.
32. Gore, S. D., L. J. Weng, and P. J. Burke. 1993. Validation of flow-cytometric determination of Ki67 expression as a measure of growth factor response in acute myelogenous leukemia. Exp. Hematol. 21: 1702-1708.
33. Lopez, F., F. Belloc, F. Lacombe, P. Dumain, J. Reiffers, P. Bernard, and M. R. Boisseau. 1991. Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry. 12: 42-49.
34. Tontonoz, P., E. Hu, R. A. Graves, A. I. Budavari, and B. M. Spiegelman. 1994. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8: 1224-1234.
35. Rosen, E. D., P. Scarraf, A. E. Troy, G. Bradwin, K. Moore, D. S. Milstone, B. M. Spiegelman, and R. M. Mortensen. 1999. PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell. 4: 611-617.
36. Yoon, J. C., P. Puigserver, G. Chen, J. Donovan, Z. Wu, J. Rhee, G. Adelmant, J. Stafford, C. R. Kahn, D. K. Granner, et al. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 413: 131-138.
37. Yoon, J. C., G. Xu, J. T. Deeney, S-N. Yang, J. Rhee, P. Puigserver, A. R. Levens, R. Yang, C-Y. Zhang, B. B. Lowell, et al. 2003. Suppression of β cell energy metabolism and insulin release by PGC-1α. Dev. Cell. 5: 73-83.
38. Hunter, S., and W. T. Garvey. 1998. Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. Am. J. Med. 105: 331-345.
39. Yokota, T., C. S. Meka, K. L. Medina, H. Igarashi, P. C. Comp, M. Takahashi, M. Nishida, K. Oritani, J. Miyagawa, T. Funahashi, et al. 2002. Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J. Clin. Invest. 109: 1303-1310.
40. Antonescu, C. R., D. H. Leung, M. Dudas, M. Ladanyi, M. Brennan, J. M. Woodruff, and C. Cordon-Cardo. 2000. Alterations of cell cycle regulators in localized synovial sarcoma: a multifactorial study with prognostic implications. Am. J. Pathol. 156: 977-983.
41. Manjeshwar, S., D. E. Branam, M. R. Lerner, D. J. Brackett, and E. R. Jupe. 2003. Tumor suppression by the prohibitin gene 3′ untranslated region RNA in human breast cancer. Cancer Res. 63: 5251-5256.
42. Morrison, R. F., and S. R. Farmer. 1999. Role of PPAR in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18 (INK4c) and p21(Waf1/Cip1), during adipogenesis. J. Biol. Chem. 274: 17088-17097.
43. Shao, D., and M. A. Lazar. 1997. Peroxisome proliferator activated receptor γ, CCAAT/enhancer-binding protein α, and cell cycle status regulate the commitment to adipocyte differentiation. J. Biol. Chem. 272: 21473-21478.
44. Freytag, S. O., D. L. Paielli, and J. D. Gilbert. 1994. Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev. 8: 1654-1663.
45. Lin, F. T., and M. D. Lane. 1994. CCAAT/enhancer binding protein α is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc. Natl. Acad. Sci. USA. 91: 8757-8761.
46. Wang, N. D., M. J. Finegold, A. Bradley, C. N. Ou, S. V. Abdelsayed, M. D. Wilde, L. R. Taylor, D. R. Wilson, and G. J. Darlington. 1995. Impaired energy homeostasis in C/EBP-alpha knockout mice. Science. 269: 1108-1112.
47. Spiegelman, B. M., L. Choy, G. Hotamisligil, R. A. Graves, and P. Tontonoz. 1993. Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J. Biol. Chem. 268: 6823-6826.
48. Kim, J. B., and B. M. Spiegelman. 1996. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 10: 1096-1107.
49. Shimomura, I., R. E. Hammer, J. A. Richardson, S. Ikemoto, Y. Bashmakov, J. L. Goldstein, and M. S. Brown. 1998. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12: 3182-3194.
50. Puigserver, P., Z. Wu, C. W. Park, R. Graves, M. Wright, and B. M. Spiegelman. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 92: 829-839.
51. Wu, Z., P. Puigserver, U. Anderson, C. Zhang, G. Adelmant, V. Mootha, A. Troy, S. Cinti, B. Lowell, B. C. Scarpulla, et al. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 98: 115-124.
52. Tsuchida, A., T. Yamauchi, Y. Ito, Y. Hada, T. Maki, S. Takekawa, J. Kamon, M. Kobayashi, R. Suzuki, K. Hara, et al. 2004. Insulin/ foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J. Biol. Chem. 279: 30817-30822.
53. Chinetti, G., C. Zawadski, J. C. Fruchart, and B. Staels. 2004. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXR. Biochem. Biophys. Res. Commun. 314: 151-158.